この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
国際貿易 · 2004/2/171 分で読めます
In the Matter of Certain Sildenafil or any Pharmaceutically Acceptable Salt Thereof, Such as Sildenafil Citrate, and Products Containing Same; Notice of Commission Decision Not to Review an Initial Determination Terminating Investigation as to One Respondent on the Basis of a Settlement Agreement; Notice of Issuance of General Exclusion Order; Termination of the Investigation
ローカル自動翻訳 · 情報源の原言語
概要
Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (Order No. 22) issued by the presiding administrative law judge ("ALJ") terminating the investigation as to respondent Biovea on the basis of a settlement agreement. Notice is also hereby given that, having previously found a violation of section 337 of the Tariff Act of 1930, 19 U.S.C. 1337, the Commission has issued a general exclusion order under section 337(d)(2) and terminated the investigation.
情報源の原言語: Federal Register — International Trade Commission原文の発表を開く →